1. Home
  2. IOVA
  3. IOVA News

Latest Iovance Biotherapeutics Inc. (IOVA) News on July 26, 2024

How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
IOVA

Zacks

a day ago

How to Find Strong Medical Stocks Slated for Positive Earnings Surprises

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
IOVA

GlobeNewswire

7 days ago

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
IOVA

Zacks

8 days ago

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

Is Iovance Biotherapeutics a Millionaire Maker?
IOVA

Motley Fool

13 days ago

Is Iovance Biotherapeutics a Millionaire Maker?

Is Iovance Biotherapeutics, Inc. (IOVA) One of the Most Shorted Stocks Loved by Analysts?
IOVA

Insider Monkey

18 days ago

Is Iovance Biotherapeutics, Inc. (IOVA) One of the Most Shorted Stocks Loved by Analysts?

Unveiling Three US Growth Companies With High Insider Ownership
IOVA

Simply Wall St.

24 days ago

Unveiling Three US Growth Companies With High Insider Ownership

IOVA

MT Newswires

a month ago

Iovance Biotherapeutics Seeks European Regulator's Approval of Marketing Authorization Application for Advanced Melanoma Treatment

Iovance Biotherapeutics Submits Marketing Authorization Application to European Medicines Agency for Lifileucel in Advanced Melanoma
IOVA

GlobeNewswire

a month ago

Iovance Biotherapeutics Submits Marketing Authorization Application to European Medicines Agency for Lifileucel in Advanced Melanoma

Is It Too Late to Buy Iovance Biotherapeutics Stock?
IOVA

Motley Fool

a month ago

Is It Too Late to Buy Iovance Biotherapeutics Stock?

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
IOVA

GlobeNewswire

a month ago

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

IOVA

MT Newswires

a month ago

JMP Securities Adjusts Price Target on Iovance Biotherapeutics to $23 From $25, Maintains Market Outperform Rating

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse
IOVA

PR Newswire

2 months ago

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse

Seibu Ikebukuro Main Store Slated for Summer 2025 Grand Re-opening as a New Department Store
IOVA

Business Wire

2 months ago

Seibu Ikebukuro Main Store Slated for Summer 2025 Grand Re-opening as a New Department Store

New Zealand scraps plan to tax livestock burps, farts
IOVA

AFP

2 months ago

New Zealand scraps plan to tax livestock burps, farts

ECB’s Lagarde Sees Multi-Meeting Rate Holds A Possibility
IOVA

The Wall Street Journal

2 months ago

ECB’s Lagarde Sees Multi-Meeting Rate Holds A Possibility

IOVA

Business Wire

2 months ago

InnoCare Announces Clearance of Clinical Trial of TYK2 Inhibitor ICP-332 by U.S. FDA

UK Unemployment Rises in Sign Inflationary Pressures Cool
IOVA

Bloomberg

2 months ago

UK Unemployment Rises in Sign Inflationary Pressures Cool

Insider-Owned Growth Companies On The Chinese Exchange In June 2024
IOVA

Simply Wall St.

2 months ago

Insider-Owned Growth Companies On The Chinese Exchange In June 2024

Here's Why New Toyo International Holdings (SGX:N08) Has Caught The Eye Of Investors
IOVA

Simply Wall St.

2 months ago

Here's Why New Toyo International Holdings (SGX:N08) Has Caught The Eye Of Investors

The Case for Buying Iovance Biotherapeutics Stock Just Got Even Better. Here's Why
IOVA

Motley Fool

2 months ago

The Case for Buying Iovance Biotherapeutics Stock Just Got Even Better. Here's Why

Exploring Three US Growth Companies With Substantial Insider Ownership
IOVA

Simply Wall St.

2 months ago

Exploring Three US Growth Companies With Substantial Insider Ownership

Iovance Biotherapeutics to Present at Upcoming Conferences and Events
IOVA

GlobeNewswire

2 months ago

Iovance Biotherapeutics to Present at Upcoming Conferences and Events

Iovance (IOVA) Up 5% on Updated Data From Melanoma Study
IOVA

Zacks

2 months ago

Iovance (IOVA) Up 5% on Updated Data From Melanoma Study

Iovance Biotherapeutics Announces Clinical Data in Frontline Advanced Melanoma at ASCO 2024 Annual Meeting
IOVA

GlobeNewswire

2 months ago

Iovance Biotherapeutics Announces Clinical Data in Frontline Advanced Melanoma at ASCO 2024 Annual Meeting

Bull Market Buys: 2 Growth Stocks to Own for the Long Run
IOVA

Motley Fool

2 months ago

Bull Market Buys: 2 Growth Stocks to Own for the Long Run

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
IOVA

GlobeNewswire

2 months ago

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

4 Small-Cap Value Stocks That Could Go Parabolic
IOVA

Motley Fool

2 months ago

4 Small-Cap Value Stocks That Could Go Parabolic

IOVA

MT Newswires

2 months ago

Truist Securities Trims Iovance Biotherapeutics' Price Target to $25 From $26, Buy Rating Maintained

IOVA

MT Newswires

2 months ago

Truist Adjusts Iovance Biotherapeutics' Price Target to $25 From $26, Keeps Buy Rating

Why Iovance Stock Is Down 18% Today
IOVA

Motley Fool

3 months ago

Why Iovance Stock Is Down 18% Today

IOVA

MT Newswires

3 months ago

Iovance Biotherapeutics' Patient Selection for Amtagvi Launch Minimizing Attrition, Truist Securities Says

Iovance Biotherapeutics Inc (IOVA) Q1 2024 Earnings: Aligns with EPS Projections Amidst Strong ...
IOVA

GuruFocus.com

3 months ago

Iovance Biotherapeutics Inc (IOVA) Q1 2024 Earnings: Aligns with EPS Projections Amidst Strong ...

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q1 2024 Earnings Call Transcript
IOVA

Insider Monkey

3 months ago

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q1 2024 Earnings Call Transcript

IOVA

MT Newswires

3 months ago

Update: Iovance Biotherapeutics Shares Fall After Q1 Revenue Misses Estimates

Iovance (IOVA) Q1 Earnings Surpass, Sales Lag Estimates
IOVA

Zacks

3 months ago

Iovance (IOVA) Q1 Earnings Surpass, Sales Lag Estimates

IOVA

Associated Press Finance

3 months ago

Iovance Biotherapeutics: Q1 Earnings Snapshot

IOVA

MT Newswires

3 months ago

Iovance Biotherapeutics Q1 Loss Narrows -- Shares Higher After Hours

Iovance Biotherapeutics Reports First Quarter 2024 Financial Results and Corporate Updates
IOVA

GlobeNewswire

3 months ago

Iovance Biotherapeutics Reports First Quarter 2024 Financial Results and Corporate Updates

Watch These 5 Drug Stocks for Q1 Earnings: Beat or Miss?
IOVA

Zacks

3 months ago

Watch These 5 Drug Stocks for Q1 Earnings: Beat or Miss?

Iovance (IOVA) Gears Up for Q1 Earnings: Here's What to Expect
IOVA

Zacks

3 months ago

Iovance (IOVA) Gears Up for Q1 Earnings: Here's What to Expect

Iovance Biotherapeutics to Host First Quarter 2024 Financial Results Conference Call and Webcast on Thursday, May 9, 2024
IOVA

GlobeNewswire

3 months ago

Iovance Biotherapeutics to Host First Quarter 2024 Financial Results Conference Call and Webcast on Thursday, May 9, 2024

Iovance Biotherapeutics to Present at Upcoming Conferences
IOVA

GlobeNewswire

3 months ago

Iovance Biotherapeutics to Present at Upcoming Conferences

With 63% ownership of the shares, Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) is heavily dominated by institutional owners
IOVA

Simply Wall St.

3 months ago

With 63% ownership of the shares, Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) is heavily dominated by institutional owners

Where Will Iovance Biotherapeutics Stock Be in 5 Years?
IOVA

Motley Fool

3 months ago

Where Will Iovance Biotherapeutics Stock Be in 5 Years?

3 Millionaire-Maker Biotech Stocks
IOVA

Motley Fool

3 months ago

3 Millionaire-Maker Biotech Stocks

20 Counties with the Highest Cancer Rates in the US
IOVA

Insider Monkey

3 months ago

20 Counties with the Highest Cancer Rates in the US

Iovance Biotherapeutics to Present Clinical and Translational Data at 2024 ASCO Annual Meeting
IOVA

GlobeNewswire

3 months ago

Iovance Biotherapeutics to Present Clinical and Translational Data at 2024 ASCO Annual Meeting

These Biotech Stocks Could Soar 120% and 295%, According to Wall Street
IOVA

Motley Fool

3 months ago

These Biotech Stocks Could Soar 120% and 295%, According to Wall Street

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
IOVA

GlobeNewswire

3 months ago

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Is Iovance Biotherapeutics Stock a Buy Now?
IOVA

Motley Fool

3 months ago

Is Iovance Biotherapeutics Stock a Buy Now?

Market Sentiment Around Loss-Making Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)
IOVA

Simply Wall St.

4 months ago

Market Sentiment Around Loss-Making Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)

Iovance (IOVA) Stock Surges More Than 60% YTD: Here's Why
IOVA

Zacks

4 months ago

Iovance (IOVA) Stock Surges More Than 60% YTD: Here's Why

Better Growth Biotech Buy: Iovance Biotherapeutics vs CRISPR Therapeutics
IOVA

Motley Fool

4 months ago

Better Growth Biotech Buy: Iovance Biotherapeutics vs CRISPR Therapeutics

Iovance Biotherapeutics (IOVA) Down 6.9% Since Last Earnings Report: Can It Rebound?
IOVA

Zacks

4 months ago

Iovance Biotherapeutics (IOVA) Down 6.9% Since Last Earnings Report: Can It Rebound?

2 Soaring Growth Stocks That Could Climb Another 47% to 73%, According to Wall Street
IOVA

Motley Fool

4 months ago

2 Soaring Growth Stocks That Could Climb Another 47% to 73%, According to Wall Street

U.S.-China Decoupling Poses Supply-Chain Risks for Drug Companies
IOVA

The Wall Street Journal

4 months ago

U.S.-China Decoupling Poses Supply-Chain Risks for Drug Companies

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
IOVA

GlobeNewswire

4 months ago

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Iovance Biotherapeutics (NASDAQ:IOVA) shareholders are still up 122% over 1 year despite pulling back 7.1% in the past week
IOVA

Simply Wall St.

4 months ago

Iovance Biotherapeutics (NASDAQ:IOVA) shareholders are still up 122% over 1 year despite pulling back 7.1% in the past week

Forget Eli Lilly. Buy This Magnificent Biotech Stock Instead
IOVA

Motley Fool

4 months ago

Forget Eli Lilly. Buy This Magnificent Biotech Stock Instead

Billionaire Paul Tudor Jones and Insiders Love These 10 Stocks
IOVA

Insider Monkey

4 months ago

Billionaire Paul Tudor Jones and Insiders Love These 10 Stocks

1 Wall Street Analyst Thinks Iovance Biotherapeutics Stock Is Going to $32. Is It a Buy Around $17?
IOVA

Motley Fool

5 months ago

1 Wall Street Analyst Thinks Iovance Biotherapeutics Stock Is Going to $32. Is It a Buy Around $17?

Iovance Biotherapeutics Stock Has 22% Upside, According to 1 Wall Street Analyst
IOVA

Motley Fool

5 months ago

Iovance Biotherapeutics Stock Has 22% Upside, According to 1 Wall Street Analyst

FDA Lifts Clinical Hold on Iovance's (IOVA) Lung Cancer Study
IOVA

Zacks

5 months ago

FDA Lifts Clinical Hold on Iovance's (IOVA) Lung Cancer Study

Iovance Biotherapeutics Announces FDA has Lifted Clinical Hold on the IOV-LUN-202 Registrational Trial in Non-Small Cell Lung Cancer
IOVA

GlobeNewswire

5 months ago

Iovance Biotherapeutics Announces FDA has Lifted Clinical Hold on the IOV-LUN-202 Registrational Trial in Non-Small Cell Lung Cancer

Could Iovance Biotherapeutics Stock Help You Become a Millionaire?
IOVA

Motley Fool

5 months ago

Could Iovance Biotherapeutics Stock Help You Become a Millionaire?

Iovance Biotherapeutics to Present at Upcoming Conferences
IOVA

GlobeNewswire

5 months ago

Iovance Biotherapeutics to Present at Upcoming Conferences

Why Iovance Biotherapeutics Stock Got Trounced on Thursday
IOVA

Motley Fool

5 months ago

Why Iovance Biotherapeutics Stock Got Trounced on Thursday

IOVA

Thomson Reuters StreetEvents

5 months ago

Q4 2023 Iovance Biotherapeutics Inc Earnings Call

Iovance's (IOVA) Q4 Earnings & Sales Fall Short of Estimates
IOVA

Zacks

5 months ago

Iovance's (IOVA) Q4 Earnings & Sales Fall Short of Estimates

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q4 2023 Earnings Call Transcript
IOVA

Insider Monkey

5 months ago

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q4 2023 Earnings Call Transcript

Iovance Therapeutics Stock Has Skyrocketed Over 100% so Far This Year. Is It Still a Buy?
IOVA

Motley Fool

5 months ago

Iovance Therapeutics Stock Has Skyrocketed Over 100% so Far This Year. Is It Still a Buy?

Iovance Biotherapeutics (IOVA) Reports Q4 Loss, Misses Revenue Estimates
IOVA

Zacks

5 months ago

Iovance Biotherapeutics (IOVA) Reports Q4 Loss, Misses Revenue Estimates

IOVA

Associated Press Finance

5 months ago

Iovance Biotherapeutics: Q4 Earnings Snapshot

Iovance Biotherapeutics Inc (IOVA) Reports Q4 and Full Year 2023 Financial Results
IOVA

GuruFocus.com

5 months ago

Iovance Biotherapeutics Inc (IOVA) Reports Q4 and Full Year 2023 Financial Results

Iovance Biotherapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates
IOVA

GlobeNewswire

5 months ago

Iovance Biotherapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates

Why Iovance (IOVA) Might Surprise This Earnings Season
IOVA

Zacks

5 months ago

Why Iovance (IOVA) Might Surprise This Earnings Season

1 Soaring Growth Stock That Could Rise Another 53%, According to Wall Street
IOVA

Motley Fool

5 months ago

1 Soaring Growth Stock That Could Rise Another 53%, According to Wall Street

Insiders Pour Millions Into These 2 Buy-Rated Stocks; Here’s Why You Might Want to Follow Their Lead
IOVA

TipRanks

5 months ago

Insiders Pour Millions Into These 2 Buy-Rated Stocks; Here’s Why You Might Want to Follow Their Lead

Is Iovance a Buy After Its First Regulatory Win?
IOVA

Motley Fool

5 months ago

Is Iovance a Buy After Its First Regulatory Win?

This Biotech Stock Has 47% Upside, According to 1 Wall Street Analyst
IOVA

Motley Fool

5 months ago

This Biotech Stock Has 47% Upside, According to 1 Wall Street Analyst

The Zacks Analyst Blog Highlights Moderna, RAPT Therapeutics, Iovance, Sarepta Therapeutics and Regeneron
IOVA

Zacks

5 months ago

The Zacks Analyst Blog Highlights Moderna, RAPT Therapeutics, Iovance, Sarepta Therapeutics and Regeneron

Iovance Biotherapeutics to Host Fourth Quarter and Full-Year 2023 Financial Results Conference Call and Webcast on Wednesday, February 28, 2024
IOVA

GlobeNewswire

5 months ago

Iovance Biotherapeutics to Host Fourth Quarter and Full-Year 2023 Financial Results Conference Call and Webcast on Wednesday, February 28, 2024

13 Best Short Squeeze Stocks To Buy Now
IOVA

Insider Monkey

5 months ago

13 Best Short Squeeze Stocks To Buy Now

Independent Director of Iovance Biotherapeutics Picks Up 78% More Stock
IOVA

Simply Wall St.

5 months ago

Independent Director of Iovance Biotherapeutics Picks Up 78% More Stock

IOVA

Argus Research

5 months ago

Daily – Vickers Top Buyers & Sellers for 02/21/2024

Iovance Biotherapeutics Stock Rockets 30% Higher
IOVA

Barrons.com

5 months ago

Iovance Biotherapeutics Stock Rockets 30% Higher

Why Iovance Biotherapeutics Stock Is Skyrocketing Today
IOVA

Motley Fool

5 months ago

Why Iovance Biotherapeutics Stock Is Skyrocketing Today

Iovance Biotherapeutics, Inc. Announces Pricing of $211 Million Underwritten Offering of Common Stock
IOVA

GlobeNewswire

5 months ago

Iovance Biotherapeutics, Inc. Announces Pricing of $211 Million Underwritten Offering of Common Stock

Iovance (IOVA) Stock Rises on FDA Nod for Melanoma Drug Amtagvi
IOVA

Zacks

5 months ago

Iovance (IOVA) Stock Rises on FDA Nod for Melanoma Drug Amtagvi

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
IOVA

GlobeNewswire

5 months ago

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

IOVA

Reuters

5 months ago

UPDATE 3-US FDA grants accelerated approval for Iovance's skin cancer cell therapy

Iovance Biotherapeutics to Host Conference Call and Webcast on Friday, February 16, 2024
IOVA

GlobeNewswire

5 months ago

Iovance Biotherapeutics to Host Conference Call and Webcast on Friday, February 16, 2024

IOVA

Reuters

5 months ago

FDA approves Iovance Biotherapeutics cell therapy for skin cancer

Iovance’s AMTAGVI™ (lifileucel) Receives U.S. FDA Accelerated Approval for Advanced Melanoma
IOVA

GlobeNewswire

5 months ago

Iovance’s AMTAGVI™ (lifileucel) Receives U.S. FDA Accelerated Approval for Advanced Melanoma

3 Opportunities for Iovance Biotherapeutics Stock, and 1 Risk
IOVA

Motley Fool

5 months ago

3 Opportunities for Iovance Biotherapeutics Stock, and 1 Risk

Is Iovance Biotherapeutics Stock a Buy Now?
IOVA

Motley Fool

6 months ago

Is Iovance Biotherapeutics Stock a Buy Now?

Is Iovance Biotherapeutics a Buy Before This Key FDA Decision?
IOVA

Motley Fool

6 months ago

Is Iovance Biotherapeutics a Buy Before This Key FDA Decision?

A Bull Market Is Here: 2 Top Growth Stocks to Buy Hand Over Fist
IOVA

Motley Fool

6 months ago

A Bull Market Is Here: 2 Top Growth Stocks to Buy Hand Over Fist

What's Next for Iovance Biotherapeutics Stock?
IOVA

Motley Fool

6 months ago

What's Next for Iovance Biotherapeutics Stock?

IOVA

Associated Press Finance

6 months ago

Viav Solutions: Fiscal Q2 Earnings Snapshot

Share on Social Networks: